INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Fundamental Analysis
NYSE:INSP • US4577301090
59.76 USD
+0.11 (+0.18%)
At close: Feb 13, 2026
59.76 USD
0 (0%)
After Hours: 2/13/2026, 8:17:41 PM
Taking everything into account, INSP scores 5 out of 10 in our fundamental rating. INSP was compared to 186 industry peers in the Health Care Equipment & Supplies industry. INSP has an excellent financial health rating, but there are some minor concerns on its profitability. INSP has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- In the past year INSP was profitable.
- In the past year INSP had a positive cash flow from operations.
- INSP had negative earnings in 4 of the past 5 years.
- In multiple years INSP reported negative operating cash flow during the last 5 years.
1.2 Ratios
- INSP has a better Return On Assets (5.52%) than 82.80% of its industry peers.
- INSP has a better Return On Equity (6.69%) than 81.18% of its industry peers.
- The Return On Invested Capital of INSP (4.82%) is better than 75.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| ROIC | 4.82% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- INSP's Profit Margin of 5.05% is fine compared to the rest of the industry. INSP outperforms 77.96% of its industry peers.
- The Operating Margin of INSP (4.16%) is better than 68.82% of its industry peers.
- INSP has a Gross Margin of 84.92%. This is amongst the best in the industry. INSP outperforms 94.62% of its industry peers.
- In the last couple of years the Gross Margin of INSP has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.16% | ||
| PM (TTM) | 5.05% | ||
| GM | 84.92% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
2. Health
2.1 Basic Checks
- INSP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- INSP has an Altman-Z score of 8.82. This indicates that INSP is financially healthy and has little risk of bankruptcy at the moment.
- INSP has a Altman-Z score of 8.82. This is amongst the best in the industry. INSP outperforms 88.17% of its industry peers.
- There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 8.82 |
ROIC/WACC0.5
WACC9.7%
2.3 Liquidity
- INSP has a Current Ratio of 5.29. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
- The Current ratio of INSP (5.29) is better than 80.65% of its industry peers.
- INSP has a Quick Ratio of 4.01. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
- INSP has a Quick ratio of 4.01. This is in the better half of the industry: INSP outperforms 75.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.29 | ||
| Quick Ratio | 4.01 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 46.82% over the past year.
EPS 1Y (TTM)46.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.48%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%12.25%
3.2 Future
- Based on estimates for the next years, INSP will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.19% on average per year.
- INSP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.28% yearly.
EPS Next Y-30.59%
EPS Next 2Y0.51%
EPS Next 3Y11.33%
EPS Next 5Y14.19%
Revenue Next Year10.7%
Revenue Next 2Y11.15%
Revenue Next 3Y11.46%
Revenue Next 5Y10.28%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 23.53, the valuation of INSP can be described as rather expensive.
- 79.03% of the companies in the same industry are more expensive than INSP, based on the Price/Earnings ratio.
- When comparing the Price/Earnings ratio of INSP to the average of the S&P500 Index (27.97), we can say INSP is valued inline with the index average.
- The Price/Forward Earnings ratio is 33.90, which means the current valuation is very expensive for INSP.
- 70.43% of the companies in the same industry are more expensive than INSP, based on the Price/Forward Earnings ratio.
- INSP's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.96.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.53 | ||
| Fwd PE | 33.9 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, INSP is valued a bit cheaper than 71.51% of the companies in the same industry.
- 92.47% of the companies in the same industry are more expensive than INSP, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.57 | ||
| EV/EBITDA | 24.34 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.51%
EPS Next 3Y11.33%
5. Dividend
5.1 Amount
- INSP does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
59.76
+0.11 (+0.18%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-11 2026-02-11/amc
Earnings (Next)05-04 2026-05-04/amc
Inst Owners111.59%
Inst Owner Change-0.27%
Ins Owners0.74%
Ins Owner Change0.1%
Market Cap1.74B
Revenue(TTM)N/A
Net Income(TTM)44.56M
Analysts76.8
Price Target131.09 (119.36%)
Short Float %10.28%
Short Ratio1.75
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)193.12%
Min EPS beat(2)114.53%
Max EPS beat(2)271.71%
EPS beat(4)4
Avg EPS beat(4)144.95%
Min EPS beat(4)54.07%
Max EPS beat(4)271.71%
EPS beat(8)8
Avg EPS beat(8)284.67%
EPS beat(12)12
Avg EPS beat(12)208.03%
EPS beat(16)16
Avg EPS beat(16)165.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.43%
Min Revenue beat(2)-0.69%
Max Revenue beat(2)-0.17%
Revenue beat(4)1
Avg Revenue beat(4)-0.14%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)0.25%
Revenue beat(12)7
Avg Revenue beat(12)1.47%
Revenue beat(16)11
Avg Revenue beat(16)3.25%
PT rev (1m)-9.17%
PT rev (3m)3.12%
EPS NQ rev (1m)31.97%
EPS NQ rev (3m)30.73%
EPS NY rev (1m)39.14%
EPS NY rev (3m)185.48%
Revenue NQ rev (1m)0.98%
Revenue NQ rev (3m)0.85%
Revenue NY rev (1m)0.29%
Revenue NY rev (3m)0.44%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.53 | ||
| Fwd PE | 33.9 | ||
| P/S | 1.97 | ||
| P/FCF | 17.57 | ||
| P/OCF | 12.99 | ||
| P/B | 2.61 | ||
| P/tB | 2.61 | ||
| EV/EBITDA | 24.34 |
EPS(TTM)2.54
EY4.25%
EPS(NY)1.76
Fwd EY2.95%
FCF(TTM)3.4
FCFY5.69%
OCF(TTM)4.6
OCFY7.7%
SpS30.37
BVpS22.93
TBVpS22.93
PEG (NY)N/A
PEG (5Y)N/A
Graham Number36.2
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| ROCE | 5.27% | ||
| ROIC | 4.82% | ||
| ROICexc | 8.98% | ||
| ROICexgc | 8.98% | ||
| OM | 4.16% | ||
| PM (TTM) | 5.05% | ||
| GM | 84.92% | ||
| FCFM | 11.2% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
F-Score8
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 276.46% | ||
| Cap/Sales | 3.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 270.95% | ||
| Profit Quality | 221.78% | ||
| Current Ratio | 5.29 | ||
| Quick Ratio | 4.01 | ||
| Altman-Z | 8.82 |
F-Score8
WACC9.7%
ROIC/WACC0.5
Cap/Depr(3y)638.93%
Cap/Depr(5y)518.49%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)46.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.48%
EPS Next Y-30.59%
EPS Next 2Y0.51%
EPS Next 3Y11.33%
EPS Next 5Y14.19%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%12.25%
Revenue Next Year10.7%
Revenue Next 2Y11.15%
Revenue Next 3Y11.46%
Revenue Next 5Y10.28%
EBIT growth 1Y172.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year658.15%
EBIT Next 3Y123.39%
EBIT Next 5Y70%
FCF growth 1Y1118.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y401.46%
OCF growth 3YN/A
OCF growth 5YN/A
INSPIRE MEDICAL SYSTEMS INC / INSP FAQ
What is the ChartMill fundamental rating of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
ChartMill assigns a fundamental rating of 5 / 10 to INSP.
Can you provide the valuation status for INSPIRE MEDICAL SYSTEMS INC?
ChartMill assigns a valuation rating of 4 / 10 to INSPIRE MEDICAL SYSTEMS INC (INSP). This can be considered as Fairly Valued.
How profitable is INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
INSPIRE MEDICAL SYSTEMS INC (INSP) has a profitability rating of 5 / 10.
What are the PE and PB ratios of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
The Price/Earnings (PE) ratio for INSPIRE MEDICAL SYSTEMS INC (INSP) is 23.53 and the Price/Book (PB) ratio is 2.61.
What is the financial health of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
The financial health rating of INSPIRE MEDICAL SYSTEMS INC (INSP) is 8 / 10.